Fundraising Fox
Monod Bio
Seattle, US · Founded 2020 · Delaware corporation · 27 employees on LinkedIn · 2 known investors
Find your way into Monod Bio
Sign up to see every warm intro you have to Monod Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Monod Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Monod Bio is a University of Washington spin-out that uses AI-powered de novo protein design to develop research-use-only tools and in vitro diagnostics. It operates in the life sciences and medical diagnostics sector.
Founders & leadership
Monod Bio was founded in 2020 by Daniel Adriano Silva Manzano, Alfredo Quijano Rubio, and Daniel Silva Manzano.
Investors · 2
Reported raises · per SEC filings
Form D private placements$30.2M disclosed across 2 of 3 rounds · 2021–2024
▶$24.2MraisedJun 2022 · 31 investors · BiotechnologyRule 506(b)
- Alfredo Quijano RubioExecutive Officer
- Daniel Adriano Silva ManzanoExecutive Officer, Director
- Karan TakharDirector
- Dave JohnsonDirector
- Berta Melina CimlerDirector
- David A ShoultzExecutive Officer, Director
- Offering amount
- $26.3M
- Amount sold
- $24.2M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$6MraisedDec 2021 · 27 investors · BiotechnologyRule 506(b)
- Daniel Adriano Silva ManzanoExecutive Officer, Director
- Dave JohnsonDirector
- David ShoultzExecutive Officer, Director
- Alfredo Quijano RubioExecutive Officer
- Berta Melina CimlerDirector
- Offering amount
- $6.1M
- Amount sold
- $6M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Monod Bio.
In the news
Frequently asked questions
- What does Monod Bio do?
- Monod Bio is a University of Washington spin-out that uses AI-powered de novo protein design to develop research-use-only tools and in vitro diagnostics. It operates in the life sciences and medical diagnostics sector.
- Who founded Monod Bio?
- Monod Bio was founded by Daniel Adriano Silva Manzano, Alfredo Quijano Rubio, Daniel Silva Manzano in 2020.
- Who are Monod Bio's investors?
- Monod Bio's investors include Global Health Investment Corporation, Pack Ventures.
- How much funding has Monod Bio raised?
- Monod Bio has disclosed $30.2M raised across 2 of its 3 known rounds.
- Where is Monod Bio headquartered?
- Monod Bio is headquartered in Seattle, US.